Surgical management of late relapse on surveillance in patients presenting with clinical stage i testicular cancer

Urology

Volumn 84, Issue 4, 2014, Pages 886-891

  Rice, Kevin R ^a,b   Beck, Stephen D W ^a,b   Pedrosa, Jose A ^a,b   Masterson, Timothy A ^a,b   Einhorn, Lawrence H ^b   Foster, Richard S ^a,b  

^a Building 9 ^*  (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; BLEOMYCIN; CHORIONIC GONADOTROPIN; CISPLATIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; OXALIPLATIN; TUMOR MARKER;

ADENOCARCINOMA; ADJUVANT THERAPY; ADULT; ALPHA FETOPROTEIN BLOOD LEVEL; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER MORTALITY; CANCER PATIENT; CANCER RECURRENCE; CANCER SPECIFIC SURVIVAL; CANCER SURGERY; CARCINOMATOSIS; CAUSE OF DEATH; CHORIOCARCINOMA; CLINICAL ARTICLE; EMBRYONAL CARCINOMA; FIBROSIS; FOLLOW UP; GERM CELL TUMOR; HORMONE BLOOD LEVEL; HUMAN; INTRATUBULAR GERM CELL CANCER; LIVER LOBECTOMY; LYMPH NODE DISSECTION; MALE; MEDICAL RECORD REVIEW; MULTIMODALITY CANCER THERAPY; NEUROECTODERM TUMOR; NON SEMINOMATOUS GERMINOMA; OUTCOME ASSESSMENT; PELVIS LYMPHADENECTOMY; PERITONEAL CARCINOMATOSIS; PERITONEUM CANCER; POSTOPERATIVE CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SALVAGE THERAPY; SEMINOMA; SYSTEMIC THERAPY; TERATOMA; TESTIS CANCER; YOLK SAC TUMOR; CANCER STAGING; MORTALITY; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, GERM CELL AND EMBRYONAL; PATHOLOGY; SURVIVAL RATE; TESTICULAR NEOPLASMS; TIME;

ADULT; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; SURVIVAL RATE; TESTICULAR NEOPLASMS; TIME FACTORS;

EID: 84921967970     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2014.05.054     Document Type: Article

References (16)

1. J. Oldenburg, J.M. Martin, and S.D. Fossa Late relapses of germ cell malignancies: incidence, management, and prognosis J Clin Oncol 24 2006 5503 5511
2. J. Baniel, R.S. Foster, and R. Gonin Late relapse of testicular cancer J Clin Oncol 13 1995 1170 1176
3. D.W. George, R.S. Foster, and R.A. Hromas Update on late relapse of germ cell tumor: a clinical and molecular analysis J Clin Oncol 21 2003 113 122
4. D.S. Sharp, B.S. Carver, and S.E. Eggener Clinical outcome and predictors of survival in late relapse of germ cell tumor J Clin Oncol 26 2008 5524 5529
5. K.P. Dieckmann, P. Albers, and J. Classen Late relapse of testicular germ cell neoplasms: a descriptive analysis of 122 cases J Urol 173 2005 824 829
6. J. Baniel, R.S. Foster, and L.H. Einhorn Late relapse of clinical stage I testicular cancer J Urol 154 1995 1370 1372
7. M.E. Gels, H.J. Hoekstra, and D.T. Sleijfer Detection of recurrence in patients with clinical stage I nonseminomatous testicular germ cell tumors and consequences for further follow-up: a single-center 10-year experience J Clin Oncol 13 1995 1188 1194
8. D. Hao, J. Seidel, and R. Brant Compliance of clinical stage I nonseminomatous germ cell tumor patients with surveillance J Urol 160 1998 768 771
9. N. Nicolai, and G. Pizzocaro A surveillance study of clinical stage I nonseminomatous germ cell tumors of the testis: 10-year followup J Urol 154 1995 1045 1049
10. G. Read, S.P. Stenning, and M.H. Cullen Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party J Clin Oncol 10 1992 1762 1768
11. T.A. Roeleveld, S. Horenblas, and W. Meinhardt Surveillance can be the standard of care for stage I nonseminomatous testicular tumors and even high risk patients J Urol 166 2001 2166 2170
12. M. Rorth, G.K. Jacobsen, and H. von der Maase Surveillance alone versus radiotherapy after orchiectomy for clinical stage I nonseminomatous testicular cancer. Danish Testicular Cancer Study Group J Clin Oncol 9 1991 1543 1548
13. P.C. Sogani, M. Perrotti, and H.W. Herr Clinical stage I testis cancer: long-term outcome of patients on surveillance J Urol 159 1998 855 858
14. T. Tandstad, G. Cohn-Cedermark, and O. Dahl Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study Ann Oncol 21 2010 1858 1863
15. H. Michael, J. Lucia, and R.S. Foster The pathology of late recurrence of testicular germ cell tumors Am J Surg Pathol 24 2000 257 273
16. C.J. Logothetis, M.L. Samuels, and A. Trindade The prognostic significance of endodermal sinus tumor histology among patients treated for stage III nonseminomatous germ cell tumors of the testes Cancer 53 1984 122 128